Addressing Involuntary Movements in Tardive Dyskinesia

NCT02291861 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
298
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Auspex Pharmaceuticals, Inc.